1. Home
  2. EDIT vs ESOA Comparison

EDIT vs ESOA Comparison

Compare EDIT & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • ESOA
  • Stock Information
  • Founded
  • EDIT 2013
  • ESOA 2006
  • Country
  • EDIT United States
  • ESOA United States
  • Employees
  • EDIT N/A
  • ESOA N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • EDIT Health Care
  • ESOA Industrials
  • Exchange
  • EDIT Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • EDIT 179.1M
  • ESOA 176.9M
  • IPO Year
  • EDIT 2016
  • ESOA 2006
  • Fundamental
  • Price
  • EDIT $2.75
  • ESOA $9.86
  • Analyst Decision
  • EDIT Buy
  • ESOA Strong Buy
  • Analyst Count
  • EDIT 12
  • ESOA 1
  • Target Price
  • EDIT $6.20
  • ESOA $21.00
  • AVG Volume (30 Days)
  • EDIT 3.3M
  • ESOA 253.4K
  • Earning Date
  • EDIT 08-06-2025
  • ESOA 08-11-2025
  • Dividend Yield
  • EDIT N/A
  • ESOA 1.20%
  • EPS Growth
  • EDIT N/A
  • ESOA 81.20
  • EPS
  • EDIT N/A
  • ESOA 1.09
  • Revenue
  • EDIT $35,837,000.00
  • ESOA $367,911,284.00
  • Revenue This Year
  • EDIT N/A
  • ESOA $8.96
  • Revenue Next Year
  • EDIT N/A
  • ESOA $7.45
  • P/E Ratio
  • EDIT N/A
  • ESOA $9.07
  • Revenue Growth
  • EDIT N/A
  • ESOA 4.62
  • 52 Week Low
  • EDIT $0.91
  • ESOA $6.50
  • 52 Week High
  • EDIT $6.05
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 61.68
  • ESOA 47.15
  • Support Level
  • EDIT $2.48
  • ESOA $9.60
  • Resistance Level
  • EDIT $3.24
  • ESOA $10.01
  • Average True Range (ATR)
  • EDIT 0.26
  • ESOA 0.54
  • MACD
  • EDIT 0.02
  • ESOA -0.03
  • Stochastic Oscillator
  • EDIT 57.94
  • ESOA 40.48

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: